EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Preoperative dose of intravenous tranexamic acid safely reduces blood loss and transfusion in patients undergoing hip hemiarthroplasty for femoral neck fracture. A randomized controlled trial

F A Miralles-Muñoz, R Martin-Grandes, M Pineda-Salazar, L L Bello-Tejeda, C DE LA Pinta-Zazo, P Farrer-Muñoz

Acta Orthopaedica Belgica · 2024

DOI: 10.52628/90.3.11635 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Acta Orthopaedica Belgica, 2024. Verfasst von F A Miralles-Muñoz und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Tranexamic Acid, Femoral Neck Fractures, Antifibrinolytic Agents, Blood Loss, Surgical. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The objectives were to evaluate the effectiveness and safety of a single preoperative dose of intravenous tranexamic acid (TXA) in reducing perioperative blood loss and requirement for transfusion in patients undergoing hip hemiarthroplasty for femoral neck fracture. A double-blind randomized controlled trial was conducted in 140 patients with hip fracture. After randomization, 68 patients received a single dose of 1 gr of intravenous TXA at the start of the surgery (TXA group), and 72 received a placebo treatment (placebo group). TXA group had a significant decrease in blood loss (p < 0.001) and requirement for transfusion (p < 0.001) compared with the placebo group. There were seven thromboembolic events, all in the placebo group (p = 0.014). Mortality within 1-year postoperatively was not significantly different between groups (p = 0.297).The use of a single dose of intravenous TXA at the start of the surgery significantly reduces blood loss and requirement for transfusion without increasing the risk of thromboembolic events in patients with femoral neck fracture undergoing hip hemiarthroplasty.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tranexamic AcidFemoral Neck FracturesAntifibrinolytic AgentsBlood Loss, SurgicalHemiarthroplastyBlood TransfusionArthroplasty, Replacement, HipHumansMaleFemaleDouble-Blind MethodAgedAged, 80 and overPreoperative CareAdministration, IntravenousMiddle Aged

Substanzen

Tranexamic AcidAntifibrinolytic Agents

Zitieren

APA

Miralles-Muñoz, F. A., Martin-Grandes, R., Pineda-Salazar, M., Bello-Tejeda, L. L., DE LA Pinta-Zazo, C., & Farrer-Muñoz, P. (2024). Preoperative dose of intravenous tranexamic acid safely reduces blood loss and transfusion in patients undergoing hip hemiarthroplasty for femoral neck fracture. A randomized controlled trial. Acta Orthopaedica Belgica. https://doi.org/10.52628/90.3.11635

Vancouver

Miralles-Muñoz FA, Martin-Grandes R, Pineda-Salazar M, Bello-Tejeda LL, DE LA Pinta-Zazo C, Farrer-Muñoz P. Preoperative dose of intravenous tranexamic acid safely reduces blood loss and transfusion in patients undergoing hip hemiarthroplasty for femoral neck fracture. A randomized controlled trial. Acta Orthopaedica Belgica. 2024. doi:10.52628/90.3.11635

BibTeX
@article{MirallesMuoz2024,
  author = {Miralles-Muñoz, F A and Martin-Grandes, R and Pineda-Salazar, M and Bello-Tejeda, L L and DE LA Pinta-Zazo, C and Farrer-Muñoz, P},
  title = {Preoperative dose of intravenous tranexamic acid safely reduces blood loss and transfusion in patients undergoing hip hemiarthroplasty for femoral neck fracture. A randomized controlled trial},
  journal = {Acta Orthopaedica Belgica},
  year = {2024},
  doi = {10.52628/90.3.11635}
}
Kostenlos starten →